Funding for this research was provided by:
Foundation for the National Institutes of Health (CCSG 5P30CA142543, NIH 1R01CA258584, NIH 1R01CA258584, U01AI156189)
Cancer Prevention and Research Institute of Texas (CPRIT RP190208, CPRIT RP190208)
Southern Methodist University (Dean’s Research Council Award 2022, Dean’s Research Council Award 2022)
Article History
Received: 5 September 2022
Accepted: 24 October 2023
First Online: 16 November 2023
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Tao Wang is one of the scientific co-founders of NightStar Biotechnologies, Inc. All remaining authors declare that they have no competing interests.